Of note, FBXO5 was found to be critically involved in immune-associated tumorigenic virus infectious diseases, including hepatitis B, hepatitis C, human T-cell leukemia virus 1 infection, and Epstein-Barr virus infection (Figures 10A–F). Here, FBXO5 is linked to hepatitis C virus infection.